NP2 COST ASSOCIATED WITH PERSISTENCY AMONG PATIENTS WITH PARTIAL SEIZURE DISORDER SWITCHING TO OXCARBAZEPINE MONOTHERAPY
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65683-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)65683-5/fulltext
Title :
NP2 COST ASSOCIATED WITH PERSISTENCY AMONG PATIENTS WITH PARTIAL SEIZURE DISORDER SWITCHING TO OXCARBAZEPINE MONOTHERAPY
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65683-5&doi=10.1016/S1098-3015(10)65683-5
First page :
Section Title :
Open access? :
No
Section Order :
49